Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study

Fig. 2

Meropenem serum concentrations vs. time after last dose (n = 48 patients). Dark blue/red circles represent concentrations of patients treated with 1000 mg/2000 mg meropenem. Light blue/orange circles represent measured meropenem serum concentration values at the end of the actual dosing interval among patients treated with 1000 mg/2000 mg meropenem

Back to article page

Critical Care

ISSN: 1364-8535